Future delivery systems for apomorphine in patients with Parkinson's disease

Adv Neurol. 1999:80:535-44.
No abstract available

MeSH terms

  • Administration, Cutaneous
  • Administration, Intranasal
  • Antiparkinson Agents / administration & dosage*
  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / pharmacokinetics
  • Antiparkinson Agents / therapeutic use
  • Apomorphine / administration & dosage*
  • Apomorphine / adverse effects
  • Apomorphine / blood
  • Apomorphine / pharmacokinetics
  • Apomorphine / therapeutic use
  • Diffusion
  • Drug Delivery Systems / trends*
  • Female
  • Humans
  • In Vitro Techniques
  • Iontophoresis
  • Middle Aged
  • Motor Activity / drug effects
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology
  • Suppositories

Substances

  • Antiparkinson Agents
  • Suppositories
  • Apomorphine